Molecular targets and therapeutics in chemoresistance of triple-negative breast cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular targets and therapeutics in chemoresistance of triple-negative breast cancer
Authors
Keywords
-
Journal
MEDICAL ONCOLOGY
Volume 39, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-11-23
DOI
10.1007/s12032-021-01610-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ninjurin 2 rs118050317 gene polymorphism and endometrial cancer risk
- (2021) Yimin Cheng et al. Cancer Cell International
- Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal study
- (2021) Hana Štorkánová et al. Scientific Reports
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- EGCG Inhibits Adipose-Derived Mesenchymal Stem Cells Differentiation into Adipocytes and Prevents a STAT3-Mediated Paracrine Oncogenic Control of Triple-Negative Breast Cancer Cell Invasive Phenotype
- (2021) Narjara Gonzalez Suarez et al. MOLECULES
- DNA N6-Methyladenine (6mA) Modification Regulates Drug Resistance in Triple Negative Breast Cancer
- (2021) Xianneng Sheng et al. Frontiers in Oncology
- First-in-Human Study of PF-06647020 (Cofetuzumab Pelidotin), an Antibody–Drug Conjugate Targeting Protein Tyrosine Kinase 7, in Advanced Solid Tumors
- (2021) Michael L. Maitland et al. CLINICAL CANCER RESEARCH
- Phase I dose-escalation trial of the oral AKT inhibitor uprosertib in combination with the oral MEK1/MEK2 inhibitor trametinib in patients with solid tumors
- (2020) Anthony W. Tolcher et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Co-targeting EGFR and mTOR with gefitinib and everolimus in triple-negative breast cancer cells
- (2020) Abderrahim El Guerrab et al. Scientific Reports
- Loss of FOXM1 in macrophages promotes pulmonary fibrosis by activating p38 MAPK signaling pathway
- (2020) Chinmayee Goda et al. PLoS Genetics
- Transcriptomic insight into salinomycin mechanisms in breast cancer cell lines: synergistic effects with dasatinib and induction of estrogen receptor β
- (2020) Vanessa Bellat et al. BMC CANCER
- Sacituzumab Govitecan-hziy: An Antibody-Drug Conjugate for the Treatment of Refractory, Metastatic, Triple-Negative Breast Cancer
- (2020) John M. Seligson et al. ANNALS OF PHARMACOTHERAPY
- Phase Ib clinical trial of the anti-frizzled antibody vantictumab (OMP-18R5) plus paclitaxel in patients with locally advanced or metastatic HER2-negative breast cancer
- (2020) Jennifer R. Diamond et al. BREAST CANCER RESEARCH AND TREATMENT
- Combined inhibition of JAK2-STAT3 and SMO-GLI1/tGLI1 pathways suppresses breast cancer stem cells, tumor growth, and metastasis
- (2020) Daniel Doheny et al. ONCOGENE
- Suppression of Tumor Growth, Metastasis, and Signaling Pathways by Reducing FOXM1 Activity in Triple Negative Breast Cancer
- (2020) Parama Dey et al. Cancers
- Apigenin by targeting hnRNPA2 sensitizes triple-negative breast cancer spheroids to doxorubicin-induced apoptosis and regulates expression of ABCC4 and ABCG2 drug efflux transporters
- (2020) Meenakshi Sudhakaran et al. BIOCHEMICAL PHARMACOLOGY
- BCL-2 Inhibitor Venetoclax Induces Autophagy-Associated Cell Death, Cell Cycle Arrest, and Apoptosis in Human Breast Cancer Cells
- (2020) Ali Alhoshani et al. OncoTargets and Therapy
- Olaparib monotherapy as primary treatment in unselected triple negative breast cancer
- (2020) H.P. Eikesdal et al. ANNALS OF ONCOLOGY
- High Oct4 expression: implications in the pathogenesis of neuroblastic tumours
- (2019) Ezequiel Monferrer et al. BMC CANCER
- Very low intensity ultrasounds as a new strategy to improve selective delivery of nanoparticles-complexes in cancer cells
- (2019) Rossella Loria et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Boolean model of growth signaling, cell cycle and apoptosis predicts the molecular mechanism of aberrant cell cycle progression driven by hyperactive PI3K
- (2019) Herbert Sizek et al. PLoS Computational Biology
- Molecular Interactions of Antibody Drugs Targeting PD-1, PD-L1, and CTLA-4 in Immuno-Oncology
- (2019) Hyun Lee et al. MOLECULES
- MiR-106a directly targets LIMK1 to inhibit proliferation and EMT of oral carcinoma cells
- (2019) Bingxia Shi et al. CELLULAR & MOLECULAR BIOLOGY LETTERS
- Bazedoxifene is a novel IL-6/GP130 inhibitor for treating triple-negative breast cancer
- (2019) Jilai Tian et al. BREAST CANCER RESEARCH AND TREATMENT
- The role of photodynamic therapy on multidrug resistant breast cancer
- (2019) Eric Chekwube Aniogo et al. Cancer Cell International
- AL101 mediated tumor inhibition in notch-altered TNBC PDX models.
- (2019) Esther Channah Broner et al. JOURNAL OF CLINICAL ONCOLOGY
- Next-Generation Hedgehog/GLI Pathway Inhibitors for Cancer Therapy
- (2019) Elisabeth Peer et al. Cancers
- Targeting Cancer Stem Cells: A Strategy for Effective Eradication of Cancer
- (2019) Masahiro Shibata et al. Cancers
- Iniparib administered weekly or twice-weekly in combination with gemcitabine/carboplatin in patients with metastatic triple-negative breast cancer: a phase II randomized open-label study with pharmacokinetics
- (2019) Véronique Diéras et al. BREAST CANCER RESEARCH AND TREATMENT
- Phase I study of ipatasertib as a single agent and in combination with abiraterone plus prednisolone in Japanese patients with advanced solid tumors
- (2019) Toshihiko Doi et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Aurora kinase A stabilizes FOXM1 to enhance paclitaxel resistance in triple‐negative breast cancer
- (2019) Na Yang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- HMGA1 promotes breast cancer angiogenesis supporting the stability, nuclear localization and transcriptional activity of FOXM1
- (2019) Rossella Zanin et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- TUFT1 Promotes Triple Negative Breast Cancer Metastasis, Stemness, and Chemoresistance by Up-Regulating the Rac1/β-Catenin Pathway
- (2019) Weiguang Liu et al. Frontiers in Oncology
- Triple-Negative Breast Cancer: The Progress of Targeted Therapies and Future Tendencies
- (2019) CHRISTOS DAMASKOS et al. ANTICANCER RESEARCH
- PI3K/AKT/mTOR pathway inhibitors in triple-negative breast cancer: a review on drug discovery and future challenges
- (2019) Mohammad A. Khan et al. DRUG DISCOVERY TODAY
- Eribulin Synergistically Increases Anti-Tumor Activity of an mTOR Inhibitor by Inhibiting pAKT/pS6K/pS6 in Triple Negative Breast Cancer
- (2019) Wei Wen et al. Cells
- Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer—How We Can Rise to the Challenge
- (2019) Nedeljković et al. Cells
- Role of miRNA-Regulated Cancer Stem Cells in the Pathogenesis of Human Malignancies
- (2019) Khan et al. Cells
- WNT Signaling in Disease
- (2019) Ng et al. Cells
- Facts and New Hopes on Selective FGFR Inhibitors in Solid Tumors
- (2019) Francesco Facchinetti et al. CLINICAL CANCER RESEARCH
- Recent advances in nanotheranostics for triple negative breast cancer treatment
- (2019) Vikram Thakur et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Targeting STAT3 in Cancer with Nucleotide Therapeutics
- (2019) Yue-Ting K. Lau et al. Cancers
- TGF-β plays a vital role in triple-negative breast cancer (TNBC) drug-resistance through regulating stemness, EMT and apoptosis
- (2018) Xiaodan Xu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single-Cell Sequencing
- (2018) Charissa Kim et al. CELL
- Pathological Response in a Triple-Negative Breast Cancer Cohort Treated with Neoadjuvant Carboplatin and Docetaxel According to Lehmann's Refined Classification
- (2018) Isabel Echavarria et al. CLINICAL CANCER RESEARCH
- Preferential Inhibition of Wnt/β-Catenin Signaling by Novel Benzimidazole Compounds in Triple-Negative Breast Cancer
- (2018) Abhishek Gangrade et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Interleukin-6 contributes to chemoresistance in MDA-MB-231 cells via targeting HIF-1α
- (2018) Ke Wang et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- FOXO3a expression is associated with lymph node metastasis and poor disease-free survival in triple-negative breast cancer
- (2018) Abdul Rehman et al. JOURNAL OF CLINICAL PATHOLOGY
- Identification of an acid sphingomyelinase ceramide kinase pathway in the regulation of the chemokine CCL5
- (2018) Benjamin Newcomb et al. JOURNAL OF LIPID RESEARCH
- Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial
- (2018) Sibylle Loibl et al. LANCET ONCOLOGY
- Transmembrane TNF-alpha promotes chemoresistance in breast cancer cells
- (2018) Zunyue Zhang et al. ONCOGENE
- Global assessment of its network dynamics reveals that the kinase Plk1 inhibits the phosphatase PP6 to promote Aurora A activity
- (2018) Arminja N. Kettenbach et al. Science Signaling
- Structural absorption by barbule microstructures of super black bird of paradise feathers
- (2018) Dakota E. McCoy et al. Nature Communications
- Metabolic consequences of HIF silencing in a triple negative human breast cancer xenograft
- (2018) Santosh K. Bharti et al. Oncotarget
- Global assessment of its network dynamics reveals that the kinase Plk1 inhibits the phosphatase PP6 to promote Aurora A activity
- (2018) Arminja N. Kettenbach et al. Science Signaling
- NOTCH3 inactivation increases triple negative breast cancer sensitivity to gefitinib by promoting EGFR tyrosine dephosphorylation and its intracellular arrest
- (2018) Giulia Diluvio et al. Oncogenesis
- Targeting the TGFβ pathway with galunisertib, a TGFβRI small molecule inhibitor, promotes anti-tumor immunity leading to durable, complete responses, as monotherapy and in combination with checkpoint blockade
- (2018) Rikke B. Holmgaard et al. Journal for ImmunoTherapy of Cancer
- TUFT1 interacts with RABGAP1 and regulates mTORC1 signaling
- (2018) Natsumi Kawasaki et al. Cell Discovery
- Paclitaxel With Inhibitor of Apoptosis Antagonist, LCL161, for Localized Triple-Negative Breast Cancer, Prospectively Stratified by Gene Signature in a Biomarker-Driven Neoadjuvant Trial
- (2018) Aditya Bardia et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of Topoisomerase IIα, PTEN, ABCC1/MRP1, and KI67 on triple-negative breast cancer patients treated with neoadjuvant chemotherapy
- (2018) Fouzia Guestini et al. BREAST CANCER RESEARCH AND TREATMENT
- Nuclear Imaging Study of the Pharmacodynamic Effects of Debio 1143, an Antagonist of Multiple Inhibitor of Apoptosis Proteins (IAPs), in a Triple-Negative Breast Cancer Model
- (2018) Pierre-Simon Bellaye et al. Contrast Media & Molecular Imaging
- N6-methyldeoxyadenine is a transgenerational epigenetic signal for mitochondrial stress adaptation
- (2018) Chengchuan Ma et al. NATURE CELL BIOLOGY
- OCT4, SOX2, and NAN OG positive expression correlates with poor differentiation, advanced disease stages, and worse overall survival in HER2+ breast cancer patients
- (2018) Fan Yang et al. OncoTargets and Therapy
- CBP/β-Catenin/FOXM1 Is a Novel Therapeutic Target in Triple Negative Breast Cancer
- (2018) Alexander Ring et al. Cancers
- MELK: a potential novel therapeutic target for TNBC and other aggressive malignancies
- (2017) Mary Kathryn Pitner et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Stathmin1 expression is associated with aggressive phenotypes and cancer stem cell marker expression in breast cancer patients
- (2017) Sayaka Obayashi et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Role of Wnt Co-Receptor LRP6 in Triple Negative Breast Cancer Cell Migration and Invasion
- (2017) Jinlu Ma et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Anthracyclines in Early Breast Cancer: The ABC Trials—USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology)
- (2017) Joanne L. Blum et al. JOURNAL OF CLINICAL ONCOLOGY
- Polymeric glabrescione B nanocapsules for passive targeting of Hedgehog-dependent tumor therapyin vitro
- (2017) Cinzia Ingallina et al. Nanomedicine
- FOXM1 recruits nuclear Aurora kinase A to participate in a positive feedback loop essential for the self-renewal of breast cancer stem cells
- (2017) N Yang et al. ONCOGENE
- Coexpression of NOS2 and COX2 accelerates tumor growth and reduces survival in estrogen receptor-negative breast cancer
- (2017) Debashree Basudhar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anti-cell growth and anti-cancer stem cell activities of the non-canonical hedgehog inhibitor GANT61 in triple-negative breast cancer cells
- (2017) Yoshikazu Koike et al. Breast Cancer
- TUFT1 is expressed in breast cancer and involved in cancer cell proliferation and survival
- (2017) Weiguang Liu et al. Oncotarget
- Molecular targeting of the Aurora-A/SMAD5 oncogenic axis restores chemosensitivity in human breast cancer cells
- (2017) Mateusz Opyrchal et al. Oncotarget
- Potential therapeutic targets of triple-negative breast cancer based on its intrinsic subtype
- (2017) Fangyuan Shao et al. Oncotarget
- STAT3/NF-κB-Regulated Lentiviral TK/GCV Suicide Gene Therapy for Cisplatin-Resistant Triple-Negative Breast Cancer
- (2017) Wei-Ying Kuo et al. Theranostics
- SRGN-TGFβ2 regulatory loop confers invasion and metastasis in triple-negative breast cancer
- (2017) Z Zhang et al. Oncogenesis
- Ceramide 1-phosphate regulates cell migration and invasion of human pancreatic cancer cells
- (2016) Io-Guané Rivera et al. BIOCHEMICAL PHARMACOLOGY
- Inhibition of Sonic Hedgehog Signaling Pathway by Thiazole Antibiotic Thiostrepton Attenuates the CD44+/CD24-Stem-Like Population and Sphere-Forming Capacity in Triple-Negative Breast Cancer
- (2016) Na Yang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Immunization against HIF-1α Inhibits the Growth of Basal Mammary Tumors and Targets Mammary Stem CellsIn Vivo
- (2016) Denise L. Cecil et al. CLINICAL CANCER RESEARCH
- CD44 targeted chemotherapy for co-eradication of breast cancer stem cells and cancer cells using polymeric nanoparticles of salinomycin and paclitaxel
- (2016) Eameema Muntimadugu et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Hypoxia‐inducible factors: coupling glucose metabolism and redox regulation with induction of the breast cancer stem cell phenotype
- (2016) Gregg L Semenza EMBO JOURNAL
- Functional and prognostic significance of the genomic amplification of frizzled 6 (FZD6 ) in breast cancer
- (2016) Gabriele Corda et al. JOURNAL OF PATHOLOGY
- Aurora-A Kinase: A Potent Oncogene and Target for Cancer Therapy
- (2016) Min Yan et al. MEDICINAL RESEARCH REVIEWS
- Combining ABCG2 Inhibitors with IMMU-132, an Anti-Trop-2 Antibody Conjugate of SN-38, Overcomes Resistance to SN-38 in Breast and Gastric Cancers
- (2016) C.-H. Chang et al. MOLECULAR CANCER THERAPEUTICS
- Punctuated copy number evolution and clonal stasis in triple-negative breast cancer
- (2016) Ruli Gao et al. NATURE GENETICS
- Aurora A kinase activates YAP signaling in triple-negative breast cancer
- (2016) S-S Chang et al. ONCOGENE
- RAC1 GTP-ase signals Wnt-beta-catenin pathway mediated integrin-directed metastasis-associated tumor cell phenotypes in triple negative breast cancers
- (2016) De Pradip et al. Oncotarget
- Pharmacological activation of FOXO3 suppresses triple-negative breast cancer in vitro and in vivo
- (2016) See-Hyoung Park et al. Oncotarget
- FOXC2 regulates the G2/M transition of stem cell-rich breast cancer cells and sensitizes them to PLK1 inhibition
- (2016) Mika Pietilä et al. Scientific Reports
- Notch3 inhibits epithelial–mesenchymal transition by activating Kibra-mediated Hippo/YAP signaling in breast cancer epithelial cells
- (2016) X Zhang et al. Oncogenesis
- Evaluating the evidence for targeting FOXO3a in breast cancer: a systematic review
- (2015) Simon Taylor et al. Cancer Cell International
- Semaphorin-3F suppresses the stemness of colorectal cancer cells by inactivating Rac1
- (2015) Jun Rao et al. CANCER LETTERS
- Wnt/ -Catenin Small-Molecule Inhibitor CWP232228 Preferentially Inhibits the Growth of Breast Cancer Stem-like Cells
- (2015) G.-B. Jang et al. CANCER RESEARCH
- Prospective study of cyclophosphamide, thiotepa, carboplatin combined with adoptive DC-CIK followed by metronomic cyclophosphamide therapy as salvage treatment for triple negative metastatic breast cancers patients (aged
- (2015) X. Wang et al. Clinical & Translational Oncology
- TBCRC 019: A Phase II Trial of Nanoparticle Albumin-Bound Paclitaxel with or without the Anti-Death Receptor 5 Monoclonal Antibody Tigatuzumab in Patients with Triple-Negative Breast Cancer
- (2015) A. Forero-Torres et al. CLINICAL CANCER RESEARCH
- Subclonal diversification of primary breast cancer revealed by multiregion sequencing
- (2015) Lucy R Yates et al. NATURE MEDICINE
- Targeting the TGFβ pathway for cancer therapy
- (2015) Cindy Neuzillet et al. PHARMACOLOGY & THERAPEUTICS
- Hypoxia-inducible factor-1α induces multidrug resistance protein in colon cancer
- (2015) Yingqian Lv et al. OncoTargets and Therapy
- The pan-PI3K inhibitor GDC-0941 activates canonical WNT signaling to confer resistance in TNBC cells: resistance reversal with WNT inhibitor
- (2015) Huey-En Tzeng et al. Oncotarget
- Genistein and Cancer: Current Status, Challenges, and Future Directions
- (2015) Carmela Spagnuolo et al. Advances in Nutrition
- Abraxane, the Nanoparticle Formulation of Paclitaxel Can Induce Drug Resistance by Up-Regulation of P-gp
- (2015) Minzhi Zhao et al. PLoS One
- Dual Aurora A and JAK2 kinase blockade effectively suppresses malignant transformation
- (2015) Hua Yang et al. Oncotarget
- Rad51 supports triple negative breast cancer metastasis.
- (2015) Adrian P. Wiegmans et al. Oncotarget
- Hippo pathway in mammary gland development and breast cancer
- (2014) P. Shi et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- The ceramide kinase inhibitor NVP-231 inhibits breast and lung cancer cell proliferation by inducing M phase arrest and subsequent cell death
- (2014) Oleksandr Pastukhov et al. BRITISH JOURNAL OF PHARMACOLOGY
- Enriched CD44+/CD24− population drives the aggressive phenotypes presented in triple-negative breast cancer (TNBC)
- (2014) Fei Ma et al. CANCER LETTERS
- Ceramide Kinase Promotes Tumor Cell Survival and Mammary Tumor Recurrence
- (2014) A. W. Payne et al. CANCER RESEARCH
- Phase I Dose-Escalation Study of MEDI-573, a Bispecific, Antiligand Monoclonal Antibody against IGFI and IGFII, in Patients with Advanced Solid Tumors
- (2014) P. Haluska et al. CLINICAL CANCER RESEARCH
- Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancer
- (2014) M. D. Burstein et al. CLINICAL CANCER RESEARCH
- Increased Hyaluronan Levels in HABP1/p32/gC1qR Overexpressing HepG2 Cells Inhibit Autophagic Vacuolation Regulating Tumor Potency
- (2014) Paramita Saha et al. PLoS One
- STAT3 Signaling Is Activated Preferentially in Tumor-Initiating Cells in Claudin-Low Models of Human Breast Cancer
- (2014) Wei Wei et al. STEM CELLS
- MELK is an oncogenic kinase essential for mitotic progression in basal-like breast cancer cells
- (2014) Yubao Wang et al. eLife
- High expression of ATP-binding cassette transporter ABCC11 in breast tumors is associated with aggressive subtypes and low disease-free survival
- (2013) Akimitsu Yamada et al. BREAST CANCER RESEARCH AND TREATMENT
- Differential Response to Neoadjuvant Chemotherapy Among 7 Triple-Negative Breast Cancer Molecular Subtypes
- (2013) H. Masuda et al. CLINICAL CANCER RESEARCH
- Role of hypoxia-inducible factors in breast cancer metastasis
- (2013) Daniele M Gilkes et al. Future Oncology
- Loss of O6-methylguanine-DNA methyltransferase confers collateral sensitivity to carmustine in topoisomerase II-mediated doxorubicin resistant triple negative breast cancer cells
- (2012) Selina Raguz et al. BIOCHEMICAL PHARMACOLOGY
- Targeting FOXM1 in cancer
- (2012) Marianna Halasi et al. BIOCHEMICAL PHARMACOLOGY
- p53 negatively regulates Aurora A via both transcriptional and posttranslational regulation
- (2012) Chun-Chi Wu et al. CELL CYCLE
- Hypoxia-inducible factor-2a is associated with ABCG2 expression, histology-grade and Ki67 expression in breast invasive ductal carcinoma
- (2012) Lei Xiang et al. Diagnostic Pathology
- A restricted cell population propagates glioblastoma growth after chemotherapy
- (2012) Jian Chen et al. NATURE
- p53 mutations in cancer
- (2012) Patricia A. J. Muller et al. NATURE CELL BIOLOGY
- Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance
- (2012) Justin M Balko et al. NATURE MEDICINE
- NANOG modulates stemness in human colorectal cancer
- (2012) J Zhang et al. ONCOGENE
- Androgen receptor expression in primary breast cancer and its predictive and prognostic value in patients treated with neoadjuvant chemotherapy
- (2011) Sibylle Loibl et al. BREAST CANCER RESEARCH AND TREATMENT
- TGF /TNF -Mediated Epithelial-Mesenchymal Transition Generates Breast Cancer Stem Cells with a Claudin-Low Phenotype
- (2011) M. K. Asiedu et al. CANCER RESEARCH
- Gli1 enhances migration and invasion via up-regulation of MMP-11 and promotes metastasis in ERα negative breast cancer cell lines
- (2011) Yeon-Jin Kwon et al. CLINICAL & EXPERIMENTAL METASTASIS
- FOXO and FOXM1 in Cancer: The FOXO-FOXM1 Axis Shapes the Outcome of Cancer Chemotherapy
- (2011) Miranda S.C. Wilson et al. CURRENT DRUG TARGETS
- Cell-surface Receptor for Complement Component C1q (gC1qR) Is a Key Regulator for Lamellipodia Formation and Cancer Metastasis
- (2011) Ki-Bum Kim et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Increased vascularity and spontaneous metastasis of breast cancer by hedgehog signaling mediated upregulation of cyr61
- (2011) L G Harris et al. ONCOGENE
- A Perspective on Cancer Cell Metastasis
- (2011) C. L. Chaffer et al. SCIENCE
- Leptin pro-angiogenic signature in breast cancer is linked to IL-1 signalling
- (2010) W Zhou et al. BRITISH JOURNAL OF CANCER
- The Mitotic Kinase Aurora-A Induces Mammary Cell Migration and Breast Cancer Metastasis by Activating the Cofilin-F-actin Pathway
- (2010) L.-h. Wang et al. CANCER RESEARCH
- Regulation of Breast Cancer Stem Cell Activity by Signaling through the Notch4 Receptor
- (2010) H. Harrison et al. CANCER RESEARCH
- The Distinct Metabolic Profile of Hematopoietic Stem Cells Reflects Their Location in a Hypoxic Niche
- (2010) Tugba Simsek et al. Cell Stem Cell
- Ceramide kinase: The first decade
- (2010) Frédéric Bornancin CELLULAR SIGNALLING
- Tremelimumab in Combination with Exemestane in Patients with Advanced Breast Cancer and Treatment-Associated Modulation of Inducible Costimulator Expression on Patient T Cells
- (2010) R. H. Vonderheide et al. CLINICAL CANCER RESEARCH
- Heterogeneity for Stem Cell-Related Markers According to Tumor Subtype and Histologic Stage in Breast Cancer
- (2010) S. Y. Park et al. CLINICAL CANCER RESEARCH
- A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF -TRCP
- (2010) B. Zhao et al. GENES & DEVELOPMENT
- Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
- (2010) Andrew Tutt et al. LANCET
- Mitochondrial p32 Protein Is a Critical Regulator of Tumor Metabolism via Maintenance of Oxidative Phosphorylation
- (2010) V. Fogal et al. MOLECULAR AND CELLULAR BIOLOGY
- Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitor
- (2010) Matthew R Janes et al. NATURE MEDICINE
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bevacizumab
- (2010) F. Kazazi-Hyseni et al. ONCOLOGIST
- Blinded by the Light: The Growing Complexity of p53
- (2009) Karen H. Vousden et al. CELL
- Pharmacogenetics of Membrane Transporters: An Update on Current Approaches
- (2009) Tristan M. Sissung et al. MOLECULAR BIOTECHNOLOGY
- Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
- (2009) C. J. Creighton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mitochondrial/Cell-Surface Protein p32/gC1qR as a Molecular Target in Tumor Cells and Tumor Stroma
- (2008) V. Fogal et al. CANCER RESEARCH
- MCF7 Side Population Cells with Characteristics of Cancer Stem/Progenitor Cells Express the Tumor Antigen MUC1
- (2008) K. Engelmann et al. CANCER RESEARCH
- Ixabepilone in Metastatic Breast Cancer: Complement or Alternative to Taxanes?
- (2008) A. R. Tan et al. CLINICAL CANCER RESEARCH
- Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
- (2008) Cornelia Liedtke et al. JOURNAL OF CLINICAL ONCOLOGY
- Plk1-dependent phosphorylation of FoxM1 regulates a transcriptional programme required for mitotic progression
- (2008) Zheng Fu et al. NATURE CELL BIOLOGY
- Transcriptional control of human p53-regulated genes
- (2008) Todd Riley et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- SOX2Silencing in Glioblastoma Tumor-Initiating Cells Causes Stop of Proliferation and Loss of Tumorigenicity
- (2008) Rosaria Maria Rita Gangemi et al. STEM CELLS
- ABC multidrug transporters: structure, function and role in chemoresistance
- (2007) Frances J Sharom PHARMACOGENOMICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started